Analyst Ratings for Onconova Therapeutics (ONTX)

ONTX Rating Summary

  |   Expand Research on ONTX
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: N/A
Rating Score: 6.3 / 10   Percentile Rank: 66%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/22/2020 Noble Capital Ahu Demir Upgrade Outperform
(Market Perform)
N/A
(N/A)
0.36
(0.59)
63.89% Details
8/24/2020 Maxim Group Jason McCarthy Downgrade Hold
(Buy)
N/A
(N/A)
1.01
(0.59)
-41.58% Details